{"version":"1.0","type":"link","title":"PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world study.","author_name":"Dieci MV 외","author_url":"https://prs-insight.online/author/Dieci%20MV","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/86116","thumbnail_width":1200,"thumbnail_height":630}